Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.1% | 14.4% | 2.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 90.4% | 91.6% | 86.7% | 85.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 14.7% | 11% | 28.6% | 37.8% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -8.1% | 6.8% | 21% | 27.1% |
| EPS Diluted | -0.004 | 0.003 | 0.01 | 0.01 |
| % Growth | -224.2% | -67% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |